Cargando…

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement

Binding to the neonatal Fc receptor (FcRn) extends serum half-life of IgG, and antagonizing this interaction is a promising therapeutic approach in IgG-mediated autoimmune diseases. Fc-MST-HN, designed for enhanced FcRn binding capacity, has not been evaluated in the context of a full-length antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brinkhaus, Maximilian, Pannecoucke, Erwin, van der Kooi, Elvera J., Bentlage, Arthur E. H., Derksen, Ninotska I. L., Andries, Julie, Balbino, Bianca, Sips, Magdalena, Ulrichts, Peter, Verheesen, Peter, de Haard, Hans, Rispens, Theo, Savvides, Savvas N., Vidarsson, Gestur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568614/ https://www.ncbi.nlm.nih.gov/pubmed/36241613 http://dx.doi.org/10.1038/s41467-022-33764-1

Ejemplares similares

Human IgE does not bind to human FcRn
por: Brinkhaus, Maximilian, et al.
Publicado: (2022)

FcRn Antagonism Leads to a Decrease of Desmoglein-Specific B Cells: Secondary Analysis of a Phase 2 Study of Efgartigimod in Pemphigus Vulgaris and Pemphigus Foliaceus
por: Maho-Vaillant, Maud, et al.
Publicado: (2022)

Characterization of the Rabbit Neonatal Fc Receptor (FcRn) and Analyzing the Immunophenotype of the Transgenic Rabbits That Overexpresses FcRn
por: Catunda Lemos, Ana Paula, et al.
Publicado: (2012)

The Neonatal Fc Receptor (FcRn): A Misnomer?
por: Pyzik, Michal, et al.
Publicado: (2019)

The neonatal Fc receptor in cancer FcRn in cancer
por: Cadena Castaneda, Diana, et al.
Publicado: (2020)

The Role of FcRn in Antigen Presentation
por: Baker, Kristi, et al.
Publicado: (2014)

Reduced FcRn-mediated transcytosis of IgG2 due to a missing Glycine in its lower hinge
por: Stapleton, Nigel M., et al.
Publicado: (2019)

Roles of FcRn in Antigen-Presenting Cells during Autoimmunity and a Clinical Evaluation of Efgartigimod as an FcRn Blocker
por: Zhou, Yihan, et al.
Publicado: (2023)

FcRn is mother’s milk to allergen tolerance
por: Lambrecht, Bart N.
Publicado: (2018)

In Translation: FcRn across the Therapeutic Spectrum
por: Qi, Timothy, et al.
Publicado: (2021)

Megalin Orchestrates FcRn Endocytosis and Trafficking
por: Dahlke, Eileen, et al.
Publicado: (2022)

Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method
por: Müller, Thomas, et al.
Publicado: (2023)

FcRn Overexpression Expands Diversity of the Humoral Immune Response in bFcRn Transgenic Mice
por: Szikora, Bence, et al.
Publicado: (2020)

FcRN receptor antagonists in the management of myasthenia gravis
por: Bhandari, Vinaya, et al.
Publicado: (2023)

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia
por: Newland, Adrian C., et al.
Publicado: (2019)

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors
por: Dalakas, Marinos C., et al.
Publicado: (2021)

Stabilization of Keratinocyte Monolayer Integrity in the Presence of Anti-Desmoglein-3 Antibodies through FcRn Blockade with Efgartigimod: Novel Treatment Paradigm for Pemphigus?
por: Zakrzewicz, Anna, et al.
Publicado: (2022)

Pharmacokinetic Models for FcRn-Mediated IgG Disposition
por: Xiao, Jim J.
Publicado: (2012)

Cell surface dynamics and cellular distribution of endogenous FcRn
por: D’Hooghe, Lena, et al.
Publicado: (2017)

Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations
por: Peter, Hans-Hartmut, et al.
Publicado: (2020)

Clinical Significance of Serum Albumin and Implications of FcRn Inhibitor Treatment in IgG-Mediated Autoimmune Disorders
por: Ward, E. Sally, et al.
Publicado: (2022)

Harnessing Fc/FcRn Affinity Data from Patents with Different Machine Learning Methods
por: Dumet, Christophe, et al.
Publicado: (2023)

FcRn receptor-mediated pharmacokinetics of therapeutic IgG in the eye
por: Kim, Hyuncheol, et al.
Publicado: (2009)

Abundant Intracellular IgG in Enterocytes and Endoderm Lacking FcRn
por: Mohanty, Sudhasri, et al.
Publicado: (2013)

Response to “The Role of FcRn in the Pharmacokinetics of Biologics in Patients with Multiple Myeloma”
por: Xu, Xu Steven, et al.
Publicado: (2017)

FcRn Expression in Wildtype Mice, Transgenic Mice, and in Human Tissues
por: Li, Tommy, et al.
Publicado: (2018)

Human FcRn Tissue Expression Profile and Half-Life in PBMCs
por: Fan, Yao-Yun, et al.
Publicado: (2019)

FcRn inhibitors: a novel option for the treatment of myasthenia gravis
por: Zhu, Li-Na, et al.
Publicado: (2023)

Characterization of the interactions of rabbit neonatal Fc receptor (FcRn) with rabbit and human IgG isotypes
por: Szikora, Bence, et al.
Publicado: (2017)

The influence of antibody engineering on Fc conformation and Fc receptor binding properties: Analysis of FcRn-binding engineered antibodies and an Fc fusion protein
por: Suzuki, Takuo, et al.
Publicado: (2021)

The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity
por: Abdiche, Yasmina Noubia, et al.
Publicado: (2015)

Treatment with anti‐neonatal Fc receptor (FcRn) antibody ameliorates experimental epidermolysis bullosa acquisita in mice
por: Kasprick, Anika, et al.
Publicado: (2020)

Podocyte-specific knockout of the neonatal Fc receptor (FcRn) results in differential protection depending on the model of glomerulonephritis
por: Dylewski, James F., et al.
Publicado: (2020)

FcRn mediated IgG transport by retinal pigment epithelium cells
por: Korthagen, Nicoline M, et al.
Publicado: (2012)

Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics
por: Schoch, Angela, et al.
Publicado: (2015)

Algorithmic multiscale analysis for the FcRn mediated regulation of antibody PK in human
por: Patsatzis, Dimitris G., et al.
Publicado: (2022)

FcRn as a Transporter for Nasal Delivery of Biologics: A Systematic Review
por: Fieux, Maxime, et al.
Publicado: (2021)

Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential
por: Stapleton, Nigel M., et al.
Publicado: (2011)

The Major Histocompatibility Complex–related Fc Receptor for IgG (FcRn) Binds Albumin and Prolongs Its Lifespan
por: Chaudhury, Chaity, et al.
Publicado: (2003)

Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics
por: Piche-Nicholas, Nicole M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rtckejinmq481piq8g81h16v6k